Corporate report

Psychoactive Substances Bill: evaluation review

An evaluation review of the Psychoactive Substances Bill by the Advisory Council on the Misuse of Drugs (ACMD).

Documents

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This ACMD report provides further advice and recommendations about the Psychoactive Substances Bill.

Updates to this page

Published 14 July 2017

Sign up for emails or print this page